Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk

Rotraut Mössner1, Peter Meyer, Florian Jankowski

  • 1Department of Dermatology, Georg-August-University, Von-Siebold-Strasse 3, D-37075 Göttingen, Germany.

Cancer Letters
|May 23, 2006
PubMed

Insights

Genetic variations in the PPARG gene were studied for their link to melanoma risk. While one study suggested a link, a second study did not replicate the findings, indicating no significant association.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Peroxisome proliferator-activated receptor (PPAR)-gamma is a nuclear receptor with tumor-suppressive roles in various cancers.
  • PPARgamma agonists have demonstrated inhibitory effects on melanoma cell line growth.
  • Investigating genetic variations in PPARG could elucidate their influence on melanoma susceptibility.

Purpose of the Study:

  • To investigate the association between specific genetic variations in the PPARG gene and the risk of developing melanoma.
  • To evaluate two common PPARG polymorphisms (P12A and C161T) in relation to melanoma risk.

Main Methods:

  • Two independent case-control studies were conducted, involving a total of 832 melanoma patients and 790 control individuals.
  • Genotyping was performed for two PPARG variations: P12A (rs1801282) and C161T (rs3856806).
  • Statistical analyses, including odds ratios and confidence intervals, were used to assess the association between genotypes and melanoma risk, adjusting for clinical factors.

Main Results:

  • The first study indicated a significantly higher frequency of homozygous carriers of the rare *T allele of the C161T polymorphism among melanoma patients compared to controls (6.0% vs. 2.0%, P=0.0096).
  • This association in the first study was independent of clinical risk factors (OR 5.18, 95% CI 1.68-15.96, P=0.0041).
  • The observed association between the C161T polymorphism and melanoma risk could not be replicated in the second independent case-control study.

Conclusions:

  • The investigated PPARG polymorphisms (P12A and C161T) are unlikely to represent a significant risk factor for melanoma development in the studied German Caucasian population.
  • Further research may be needed to fully understand the complex genetic underpinnings of melanoma susceptibility.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...